Unjha Formulations Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling mandatory regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The pharmaceutical company submitted the certificate for the quarter and year ended March 31, 2026, demonstrating adherence to securities market regulations.

Regulatory Compliance Submission

The company submitted its certificate under Regulation 74(5) of SEBI regulations on April 10, 2026, through a formal communication to BSE's Listing Department. Managing Director Krutiben M. Patel signed the submission letter, ensuring proper authorization of the regulatory filing.

Transfer Agent Confirmation

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, served as the company's registrar and transfer agent for the reporting period. The transfer agent issued a confirmation certificate dated April 1, 2026, validating the proper handling of dematerialization processes.

The transfer agent confirmed that all securities received from depository participants for dematerialization during the quarter ended March 31, 2026, were processed according to regulatory requirements. The confirmation covered several key compliance areas:

• Securities received for dematerialization were confirmed or rejected to depositories within prescribed timelines
• Security certificates were properly mutilated and cancelled after verification
• Depository names were substituted in the register of members as registered owners
• All securities remained listed on stock exchanges where previously issued securities are traded

Corporate Information

The company operates from its registered office at Khali Char Rasta, State Highway, Sidhpur, Mahesana, with PIN code 384151. Ashok Shetty, Senior Vice President of Corporate Registry at MUFG Intime India Private Limited, signed the transfer agent's confirmation certificate.

Regulatory Framework

Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 mandates listed companies to obtain and submit confirmation certificates from their registrar and transfer agents. This requirement ensures transparency in dematerialization processes and maintains investor confidence in securities market operations.

The filing demonstrates Unjha Formulations Limited's commitment to regulatory compliance and proper corporate governance practices in securities market operations.

Unjha Formulations Limited's promoter group has submitted updated mandatory shareholding disclosures to BSE Limited, revealing their collective stake in the pharmaceutical company as on April 1, 2026. The disclosure, filed under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, specifically under Regulation 31(4), provides transparency regarding promoter group holdings exceeding 25% of the company's share capital.

Updated Promoter Group Shareholding Details

The promoter group collectively holds 1654424 shares, representing 36.92% of Unjha Formulations Limited's total share capital and voting rights. The latest disclosure encompasses both direct shareholdings and persons acting in concert (PAC) within the promoter group as on April 1, 2026.

Regulatory Compliance Framework

The disclosure was submitted in compliance with Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The company received disclosures from all promoter group members covering their shareholdings as on April 1, 2026, with the formal submission made to BSE Limited on April 2, 2026.

Key Disclosure Parameters

The filing covers various categories of holdings including equity shares, voting rights, warrants, convertible securities, and other instruments that could entitle holders to receive shares in the target company. All disclosed holdings are in the form of equity shares with no convertible instruments reported.

Promoter Group Structure and PAN Details

The promoter group comprises family members with defined relationships and individual PAN identifications. The disclosure includes specific PAN numbers for each promoter: Jashodaben Shambhubhai Patel (AFVPP8472P), Krutiben Mayankkumar Patel (AFVPP8468B), Urveshkumar Shambhubhaipatel (ACDPP8625P), and Neenaben Urveshkumar Patel (AFVPP8467Q).

Krutiben Mayankkumar Patel, who serves as Managing Director (DIN: 01866427), holds 14.89% of the company's shares and signed the disclosure documents on behalf of the company. The disclosure ensures transparency in promoter shareholding patterns and compliance with SEBI's substantial acquisition regulations, providing investors with clear visibility into the ownership structure of Unjha Formulations Limited.